Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis
ConclusionsA large proportion of AS not on biologics have active disease far into the disease course. This impacts negatively on quality of life, work ability, and spinal mobility. Serum cytokine levels are poor markers for these central disease features in AS management.FundingAbbott Norway AS and Arthritis Foundation of Western Australia.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Australia Health | Back Pain | Chronic Pain | Laboratory Medicine | Norway Health | Pain | Pain Management | Rheumatology | Study